RB1 and adenocarcinoma: They are referred to as C4-2BER (by continuous exposure of adenocarcinoma cell line C4-2B to enzalutamide) and DKD (depleting RB1 along with TP53 from adenocarcinoma cell line LNCaP C4-2) respectively [19].